MSCV (cat# 24828), MSCV EZH2 ΔSET-Hygro (cat# 49403) EZH2-Y641-F (cat# 80077), pTRIPZ M)-YFP-EZH2 (cat# 82511), MSCV-EZH2OE (cat#75125), MSCV–EZH2EZH1SET (cat#75126) were procured from Addgene USA. Control (MSCV), EZH2 ΔSET-Hygro, and EZH2-Y641-F cell lines were generated by utilizing a retroviral-mediated transduction system followed by puromycin selection. The HEK293-T (ATCC- CRL-3216) cell line was used for the generation of viral particles following standard protocol. The HEK293-T cells were plated in the 6-well plate at 80% confluency. Polybrene (8 μg/ml) was added to the viral soup during the transduction of matured viral particles into the target cells. MSCV control cells were subjected to puromycin, and EZH2 Y641-F and EZH2 ΔSET cells were subjected to hygromycin selection, and the overexpression of stable EZH2, ΔSET, and EZH2-Y641-F was confirmed by western blot. Following the same protocol reported in our recent publication66 EZH2 mouse, KRT14 mouse, and Human shRNA, SP1 mouse, and human and UTX mouse shRNA sequence were cloned in the 3rd generation transfer plasmid pLKO.1 TRC cloning vector (Addgene cat # 10878) between unique AgeI and EcoRI restriction sites downstream of the U6 promoter. HEK-293T cell line was used for the generation of lentiviral particles, and media containing the viral particles was supplemented with Polybrene (8 μg/ml) for the transduction purpose. Cells were subjected to puromycin selection after 48 h of transduction, and the knockdown for EZH2 and KRT14 was confirmed by western blot. shRNA sequences were listed in Supplementary Table 4.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.